Northeast Dermatology Conference 2024
Newport, Rhode Island

April 12-13, 2024

Meet Our Esteemed Faculty

Luiza Kalil , MD

Amit Garg, MD

Linda Stein Gold, MD

Luiza Kalil , MD

Amit Garg, MD

Linda Stein Gold, MD

Alice Gottlieb, MD, PhD

Pearl Kwong, MD

Kati Midgley, PA-C

Alice Gottlieb, MD, PhD

Jason Lee, MD

Kati Midgley, PA-C

Vanessa Pomarico, APRN

Marc Serota, MD

Mona Shahriari, MD

Kati Midgley, PA-C

Vanessa Pomarico, APRN

Marc Serota, MD

Neda Shahriari, MD

James Song, MD

Bruce Strober, MD, PhD

James Song, MD

James Song, MD

Bruce Strober, MD, PhD

Join us in picturesque Newport, Rhode Island for the 2024 Northeast Dermatology Conference tailored for Dermatology NPs and PAs. Our choice of this intimate setting is aimed at providing our members and the Northeast Dermatology Community a platform to learn, connect, and collaborate as a cohesive group. This regional conference will emphasize open educational dialogues with prominent thought leaders in dermatology, networking opportunities with colleagues and industry partners, and a welcoming environment to cultivate enduring relationships that will aid our colleagues in effecting positive changes within their practice.

Alice Gottlieb, MD, PhD

Alice Bendix Gottlieb MD, PhD, Medical Director and Clinical Professor, Mount Sinai Beth Israel Dermatology, Kimberly and Eric J. Waldman Department of Dermatology at The Icahn School of Medicine at Mount Sinai , is a superb physician who has made a significant mark in the scientific fields of Dermatology and Rheumatology.

After graduating from Brandeis University Summa Cum Laude with Honors in Chemistry, Dr. Gottlieb entered the combined MD-PhD program at The Rockefeller University-Cornell University Medical College where she was one of the first females to be admitted into the program. She received her PhD from the Rockefeller Unversity in 1979 forllowed by her MD at Cornell University Medical Center in 1980. Dr. Gottlieb entered The New York Hospital for her internal medicine residency, which she completed in 1982, followed by a rheumatology fellowship at the Hospital for Special Surgery completed in 1984 and returned to the New York Hospital for her dermatology residency which she completed in 1993.. Dr. Gottlieb founded the Tufts Dermatology residency program (which formally was shared with Boston University) and served as Chair of Dermatology and Dermatologist-in-Chief of Tufts Medical Center. She also founded the Dermatology Division at UMDNJ-Robert Wood Johnson Medical School where she served as Professor of Medicine, Director of the Clinical Research Center and Founding Director of the Psoriasis Center of Excellence. Before joining the Mt Sinai faculty she was a Professor of Dermatology at New York Medical College in New York City.

Dr. Gottlieb is an internationally recognized expert in the field of psoriasis, psoriatic arthritis and hidradenitis suppurativa . Her research uses targeted immunobiologics as pathogenic probes, providing new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. Through a study she had published in Lancet in 2001, Dr. Gottlieb was the first to show the efficacy of TNF blockers as monotherapy for moderate to severe psoriasis. Her research led to multiple TNF blockers being FDA-approved for psoriasis which revolutionized the care of psoriasis and psoriatic arthritis patients. In addition, Dr. Gottlieb was one of the first scientists to demonstrate that psoriasis is a T cell mediated disease. She showed that treatment with a T cell-specific immunotoxin cleared psoriasis clinically and histologically. With her published studies and public presentations she has been able to convince pharmaceutical companies to use psoriasis as their proof-of-concept disease when testing new immunomodulators that may decrease T cell and dendritic cell cytokine production. So far, her research has affected drug development in psoriasis, psoriatic arthritis, hidradenitis suppurativa, rheumatoid arthritis, inflammatory bowel disease and transplantation.

Through her research, Dr. Gottlieb has authored over 500 peer-reviewed articles making appearances in journals, such as the Lancet, the Journal of Experimental Medicine, Journal of Investigative Dermatology, Archives of Dermatology, the Journal of the American Academy of Dermatology, the New England Journal of Medicine. Additionally, she has presented her research at more than 353 dermatology and rheumatology conferences in Asia, Europe and the United States, as well as the FDA and the National Academy of Sciences. In 2001, she was the recipient of the American Skin Association’s Psoriasis Research Achievement Award in recognition of her “important contributions to the scientific understanding of psoriasis”. In a survey of top psoriasis experts from around the world, Dr. Gottlieb came in first place with 1506 first author citations. She continues her innovative clinical research at Mount Sinai.

In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple boarded in dermatology, rheumatology and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents and fellows she has trained, as well as the dermatologic community at large, who want to understand how to diagnose and manage psoriatic arthritis. She is an excellent teacher which is why it is no surprise she has won the Excellence in Teaching Award from the Department of Dermatology at Tufts University Medical School/Tufts Medical Center. In 2016 she received ther National Psoriasis Foundation Outstanding Educator in Psoriatic Disease Award In 2018, she was honored with an award from the National Psoriasis Foundation for her leadership in psoriasis and psoriatic arthritis research and care. In 2021, she received the Outstanding Scientific Achievement Award from the National Psoriasis Foundation. In 2023 she received 4 awards or significant recognitions:

The Everett Fox Lectureship Award from the AAD, Aug, 11, 2023
Newsweek’s one of the Best Dermatologists in the USA for 2023
Teacher of the Year 2023 awarded by the Department of Dermatology, Icahn School of Medicine at Mt Sinai, NY, NY
American Academy of Dermatology’s 2023 Master Dermatologist Award

Dr. Gottlieb is the recipient of numerous awards including Excellence in Teaching Award from the Department of Dermatology at Tufts University Medical School/Tufts Medical Center, Honorary Membership in Alpha Omega Alpha in recognition of medical student teaching, a Research Mentorship award from the Internal Medicine house staff and a Mentorship Award from the American Chemical Society for mentoring minority high school students in bench and clinical research. She was elected to the Board of Directors of the American Academy of Dermatology for 2011-2015.She is a member of the American Dermatologic Association and others.

Over the course of her illustrious career, she held many important leadership positions the Board of Directors for the American Academy of Dermatology and the Women’s Dermatologic Society, and Chairman, Networking Committee of the Women’s Dermatologic Society, as well serving as a Medical Advisory Board member and Editor in Chief of the Journal of Psoriasis and Psoriatic Arthritis, which is physicians’ journal of the National Psoriasis Foundation. In 2015, she has been awarded the Honorary Membership into the American Academy of Dermatology for her exceptional leadership and service.

Dr. Gottlieb has served on the Editorial Board of the Journal of Cutaneous Medicine and Surgery and American Academy of Dermatology, the American Clinical Dermatology, Editor in Chief of the Journal of Psoriasis and Psoriatic Arthritis and Editor, Dermatology Section of Clinical Immunology. She is also an elected member of the Noah Worcester Dermatologic Society and the Association of Professors of Dermatology.

She is the founder and President of the International Dermatology Outcome Measures (IDEOM) group. Founded in 2013, this 501c3 non-profit, consortium of patients, physicians, pharmaceutical scientists and other stakeholders is dedicated to bringing outcome measures to dermatologic clinical research and practice that satisfy the needs of all stakeholders. She is on the Executive Board of GRAPPA, the group devoted the research in psoriasis and psoriatic arthritis. She is a councilor of the International Psoriasis Council.

Dr. Gottlieb practices at the Mount Sinai Beth Israel where she puts her patients first and she continues her innovative clinical research in psoriasis, psoriatic arthritis, hidradenitis suppurativa and vitiligo and other immune mediated disorders. She continues to enjoy her mentoring and teaching of the dermatology residents, young faculty and medical students.

Jason Lee, MD

Dr. Jason B. Lee graduated from the University of California, Irvine with degrees in Philosophy and Biological Science in 1987. He received his medical degree in Philadelphia from Sidney Kimmel Medical College, the class of 1993. He completed his residency in dermatology at Thomas Jefferson University and subsequently completed a dermatopathology fellowship with A. Bernard Ackerman, finishing in 1998. He worked with Dr. A. Bernard Ackerman in New York early in his career but his academic career at Jefferson became firmly entrenched, attaining the academic rank of Professor in 2012. Throughout his career at Jefferson, he has held vital leadership roles in the department of dermatology that include serving as the medical director, and Vice-Chair of the Department of Dermatology. He served as the residency director from 2005 to 2017 and dermatopathology fellowship director from 2008 to the present. Dr. Lee is a member of numerous societies that are local, regional, and national. He served in many committees over the years including the American Academy of Dermatology and American Society of Dermatopathology. He has been very active in local societies, serving as the President of the Philadelphia Dermatological Society (2008-2009) and President of the Section on Dermatology of the College of Physicians of Philadelphia (2012-2015).

He has authored over 130 articles in peer-reviewed articles. He co-authored many book chapters and has lectured extensively locally, regionally, nationally, and internatioanlly, particularly on the topic on histopathological correlate of dermatoscopic structures, diagnostic errors, and melanoma diagnosis. He has participated and organized many dermatopathology courses in recent years, both at the regional and national level. He has been an invited guest lecturer at many academic institutions.

Of all the roles Dr. Lee has held throughout his career, his most treasured role has been the clinician educator role in which he taught residents and fellows foundational knowledge and skills in dermatology and dermatopathology, emphasizing historical perspective and critical thinking, influenced by the teachings of Dr. Ackerman. Dr. Lee has taught clinical dermatology through dermatopathology, always emphasizing the knowledge of dermatopathology necessary to provide excellence in patient-centered care that not only meets the standard of care but also exceeds it. Clinical pathologic correlation (CPC) served as the cornerstone of teaching dermatology as he directed over 20 years of weekly CPC conference at Jefferson. He has inspired many of his trainees to become the next generation of academic dermatologists and dermatopathologists. Half of his graduated dermatopathology fellows have pursued a career at an academic institution.

Dr. Lee’s philosophical approach has been for dermatopathology to be accessible, teachable, and applicable to daily dermatology practice. To that end, his most recent accomplishment has been a production of a virtual dermatopathology review course for dermatology residents and dermatopathology fellows in which over 350 participants were able to access, without a fee, nearly 250 virtual slides and corresponding lectures.

Bruce Strober, MD, PhD

Dr. Strober earned both his medical and his doctorate degrees from Columbia University in New York, New York. He subsequently completed his residency in dermatology in the Department of Dermatology, New York University School of Medicine in New York, New York. He is board certified by the American Board of Dermatology and a Fellow in the American Academy of Dermatology.

Dr. Strober’s research interests include the study of therapeutics, both old and new, for inflammatory skin disease, specifically interventions that help patients with difficult-to-treat psoriasis, atopic dermatitis, and hidradenitis suppurativa. Additional research interests include elucidation of novel features of inflammatory skin disease not previously uncovered and assisting in the clarification of the pathophysiology of inflammatory skin disease. He has served as principal investigator or sub-investigator for numerous multicenter clinical studies.

Dr. Strober is Clinical Professor of Dermatology at Yale University School of Medicine. He is currently the Editor in Chief of the Journal of Psoriasis and Psoriatic Arthritis. Dr. Strober has served as a Section Editor for the British Journal of Dermatology, and an ad hoc reviewer for Journal of the American Academy of Dermatology, JAMA Dermatology, British Journal of Dermatology, and the New England Journal of Medicine. He has published more than 195 book chapters and articles in peer-reviewed journals such as JAMA Dermatology, the New England Journal of Medicine, Journal of the American Academy of Dermatology, and the Journal of Investigative Dermatology, the Journal of the American Medical Association, among others. Dr. Strober also has frequently presented data to the FDA, including at the advisory committee for secukinumab, a novel IL-17 inhibitor for the treatment of psoriasis. He currently is the treasurer on the Board of the International Psoriasis Council and Scientific Co-Director of the CorEvitas Psoriasis Registry.

His primary clinical focus is the treatment of difficult-to-treat inflammatory diseases of the skin, such as psoriasis, atopic dermatitis and hidradenitis suppurativa.

Prior to co-founding Central Connecticut Dermatology, Dr. Strober was Professor and Chair in the Department of Dermatology, University of Connecticut School of Medicine in Farmington, Connecticut.